Furthermore, it is intriguing whether other non-IL-17R inflammatory receptors including TNFR, IL-1R and TLR may also control tumor-specific proliferation in a manner that we have demonstrated for IL-17RC. This evidence concerns the gene IL1R1 and neoplasm.